Hemp Bombs® Adds to Award-Winning Gummies Lineup with New Delta-8 and Delta-9 Sleep Gummies
August 26th, 2022
– Newest gummies are first in Hemp Bombs’ product line to feature CBN –
TAMPA, Fla., Aug. 26, 2022 /PRNewswire/ — Hemp Bombs®, the manufacturer and distributor of award-winning CBD, Delta-8 THC and Delta-9 THC Gummies, announces its newest additions to its gummy line, Delta-8 Sleep Gummies and Delta-9 Sleep Gummies. These are the first Hemp Bombs gummies to contain the cannabinoid CBN.
“As our experience and reputation shows from manufacturing award-winning, industry-leading CBD, Delta-8 and Delta-9 gummies, innovation is key,” said Vince Gillen, vice president of sales. “Our distribution and retail partners continue to drive our growth across multiple channels with new products that consumers trust and rely on.”
Last year, Hemp Bombs original Delta-8 THC Gummies were named a 2021 Retailer Choice Best New Product by CSP Magazine. Hemp Bombs Delta-8 Sleep Gummies feature 25mg of Delta-8 THC, 5mg of CBN and Hemp Bombs’ proprietary calming blend including chamomile, lemon balm, passionflower and lavender extracts. They come in a Cherry Haze flavor and a 30-count bottle has an MSRP of $38.99.
Hemp Bombs Delta-9 Sleep Gummies contain 10mg of Delta-9 THC, 5mg of CBN and the same proprietary calming blend. They also feature a cherry flavor and are available in 30-count bottles with an MSRP of $44.99.
Customers can also take advantage of new bundles designed to help them save money and enjoy the full selection of Hemp Bombs Delta-8 and Delta-9 gummies. These bundles feature a combination of either a 50-count bottle of Delta-8 or Delta-9 Gummies and a 30-count bottle of Delta-8 or Delta-9 Sleep Gummies with savings up to $22 off the retail price.
Federally compliant under the 2018 Farm Bill, all Hemp Bombs THC Gummies are independently lab tested to ensure safety and compliance with all state and federal regulations.
All Hemp Bombs products are crafted and manufactured by its in-house team of more than 300 employees across four manufacturing and distribution locations in Tampa, Florida.
For more information about its commitment to providing the highest-quality Delta-8 and Delta-9 products and to shop Delta-8 and Delta-9 THC Gummies, visit https://hempbombsplus.com/.
Hemp Bombs®, founded in 2016 and headquartered in Tampa, Florida, is a manufacturer and distributor of hemp-derived CBD, Delta-8 and Delta-9 cannabinoid products. With more than 150,000 square feet of manufacturing space and over 300 employees, Hemp Bombs manufactures edibles, tinctures, topicals and pet products. Its award-winning gummies and other products are available in more than 20,000 locations nationwide and online at https://hempbombs.com/ and https://hempbombsplus.com/.
Joe Agostinelli, PR Manager
813-497-5752| [email protected]
SOURCE Hemp Bombs
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.